Literature DB >> 15544549

Cellular and physiological effects of soy flavonoids.

Tatiana Valachovicova1, Veronika Slivova, Daniel Sliva.   

Abstract

Recent experimental and epidemiological studies have provided convincing evidence for a variety of health benefits derived from the consumption of soy and soy food products. For example, soy isoflavones are felt to protect against different cancers, cardiovascular disease, and bone loss. Many studies have demonstrated the effect of soy isoflavones on specific target molecules and signaling pathways, including but not limited to, cell proliferation and differentiation, cell cycle regulation, apoptosis, angiogenesis, cell adhesion and migration, metastasis, and activity of different enzymes. Isoflavones also share structural homologies with estrogens and are therefore classified as phytoestrogens with weak estrogenic properties. Since isoflavones bind to estrogen receptors (ER alpha and ER beta), they are considered to be possible estrogen receptor modulators. However, isoflavones can also exert biological effects independent of their phytoestrogenic activities. Recent studies suggest beneficial health effects of soy and recommend increasing the intake of isoflavone-rich soy protein to the level of intake commonly used in Asian countries.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544549     DOI: 10.2174/1389557043403387

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  11 in total

Review 1.  Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems.

Authors:  Vijay K Singh; Thomas M Seed
Journal:  Expert Opin Pharmacother       Date:  2020-01-11       Impact factor: 3.889

Review 2.  The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome.

Authors:  Dana C Dolinoy
Journal:  Nutr Rev       Date:  2008-08       Impact factor: 7.110

3.  Calycosin promotes angiogenesis involving estrogen receptor and mitogen-activated protein kinase (MAPK) signaling pathway in zebrafish and HUVEC.

Authors:  Jing Yan Tang; Shang Li; Zhen Hua Li; Zai Jun Zhang; Guang Hu; Lorita Chi Veng Cheang; Deepa Alex; Maggie Pui Man Hoi; Yiu Wa Kwan; Shun Wan Chan; George Pak Heng Leung; Simon Ming Yuen Lee
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

Review 4.  Dietary polyphenols in prevention and treatment of prostate cancer.

Authors:  Rahul K Lall; Deeba N Syed; Vaqar M Adhami; Mohammad Imran Khan; Hasan Mukhtar
Journal:  Int J Mol Sci       Date:  2015-02-03       Impact factor: 5.923

5.  Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway.

Authors:  Panhong Fan; Shujun Fan; Huan Wang; Jun Mao; Yu Shi; Mohammed M Ibrahim; Wei Ma; Xiaotang Yu; Zhenhuan Hou; Bo Wang; Lianhong Li
Journal:  Stem Cell Res Ther       Date:  2013       Impact factor: 6.832

Review 6.  New approaches to radiation protection.

Authors:  Eliot M Rosen; Regina Day; Vijay K Singh
Journal:  Front Oncol       Date:  2015-01-20       Impact factor: 6.244

Review 7.  Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis.

Authors:  Catherine C Applegate; Joe L Rowles; Katherine M Ranard; Sookyoung Jeon; John W Erdman
Journal:  Nutrients       Date:  2018-01-04       Impact factor: 5.717

8.  The phytoestrogen genistein affects zebrafish development through two different pathways.

Authors:  Sana Sassi-Messai; Yann Gibert; Laure Bernard; Shin-Ichi Nishio; Karine F Ferri Lagneau; José Molina; Monika Andersson-Lendahl; Gérard Benoit; Patrick Balaguer; Vincent Laudet
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

9.  Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome.

Authors:  Dana C Dolinoy; Jennifer R Weidman; Robert A Waterland; Randy L Jirtle
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

10.  Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol.

Authors:  A Bitto; B P Burnett; F Polito; H Marini; R M Levy; M A Armbruster; L Minutoli; V Di Stefano; N Irrera; S Antoci; R Granese; F Squadrito; D Altavilla
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.